NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,072,959 | +2.3% | 10,534 | +1.4% | 0.16% | +18.4% |
| Q2 2023 | $1,048,623 | +8.8% | 10,392 | -0.8% | 0.14% | +7.1% |
| Q1 2023 | $964,037 | +2.5% | 10,479 | +1.1% | 0.13% | -3.1% |
| Q4 2022 | $940,522 | +19.8% | 10,367 | +0.4% | 0.13% | +4.0% |
| Q3 2022 | $785,000 | -10.3% | 10,330 | -0.3% | 0.13% | -6.0% |
| Q2 2022 | $875,000 | -4.7% | 10,356 | -1.0% | 0.13% | +8.1% |
| Q1 2022 | $918,000 | -0.2% | 10,457 | -0.6% | 0.12% | +1.6% |
| Q4 2021 | $920,000 | +7.6% | 10,518 | +2.3% | 0.12% | +6.1% |
| Q3 2021 | $855,000 | -9.5% | 10,278 | -0.7% | 0.12% | -11.5% |
| Q2 2021 | $945,000 | +28.2% | 10,352 | +20.0% | 0.13% | +19.3% |
| Q1 2021 | $737,000 | -9.3% | 8,626 | +0.2% | 0.11% | -22.1% |
| Q4 2020 | $813,000 | – | 8,606 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |